Home > Press > BIT’s 7th Annual Congress of International Drug Discovery Science and Technology (IDDST)
Abstract:
Theme: Milestones of Innovative Therapeutics
Time: October 22-25, 2009
Venue: Everbright Convention and Exhibition Center, Shanghai, China
BIT Life Sciences and Organizing Committee is organizing the 7th Annual Congress of International Drug Discovery Science and Technology (IDDST) as part of their dedication to offer professionals in drug discovery field a multidisciplinary platform to learn about the latest scientific updates and current industry standards. The congress, with the theme "Milestones of Innovative Therapeutics" will be held October 22-25, 2009, in the Everbright Convention and Exhibition Center, Shanghai China. On behalf of the organizing committee, we're pleased to welcome you to join us and give a speech at the congress, and hope you can bring your knowledge and experience to share with other business and research leaders, where you're encouraged to network and explore partnering opportunities.
The IDDST congress is initiated by BIT Life Sciences in 2003, with 6 years' contribution in this field, it has attracted more 800 world renowned speakers with over 40,000 professionals around the world as a leading international event for the professionals to pinpoint and identify opportunities and market needs, explore Asian demand, and get updated on the latest breakthroughs in drug R&D.
2009 is an exciting time for those in the drug discovery and development field once again. With an emphasis on practical, actionable ideas for accelerating discovery and early development, the 7th Congress will be a great opportunity for the world's leading scientists and executives to share with you the latest advancements in pharmic studies and their strategic approaches to win the race to bring in the next blockbuster drug to market, and milestones of innovative therapeutics. Through the IDDST Congress 2009, you will gain full coverage on up-to-date information within the booming drug R&D industry and its partnering potential in Asia, and also deeply understand the market to get what you need, such as the strategies of major pharma players in integrating scientific, technological, talent and business resources in a flat world to increase business competitive capacities.
For IDDST 2009, BIT Life Sciences is pleased to provide the participants:
* Access to All Eight Tracks Program
* Gain Insights into Therapeutics Area
* Network with 1200+ Participants
* Present Your Research in over 60+ Sessions
* View the Latest Technology and Services in over 100+ Exhibitions
* Develop Strategic Relationships by Interactive Roundtable Discussions
In addition to the outstanding program, you will be able to enjoy the culture and sights of Shanghai, one of largest and most prosperous cities in China. There are many excursions to suit your interests. October is a wonderful time to visit, and we encourage you to extend your trip and get to know the rest of China as well. We look forward to seeing you in Shanghai for a stimulating and enjoyable conference.
Call for Abstracts for oral presentation and posters:
We invite abstracts of proffered papers on the Biopharmaceuticals, Cellular Hit Identification
Chemistry, Clinical Pharmacology, Clinical R&D, DMPK, Drug Safety & Metabolism, Enabling Technologies, HTS, Lead Discovery & Profiling, Medicinal Chemistry, Microbiology, Molecular Pharmacology, Pharmacokinetics, R&D, Structural Biochemistry, Target Discovery, Toxicology, Translational Sciences, etc. Topics are not limited to the above; any new proposed topic is welcomed. Abstracts of superior quality will be selected by the Committee for presentation after abstracts submitted within 2 weeks, and published in the congress meeting book. They will be available for viewing online at the website, along with slide presentations and posters.
Call for Exhibitors
Exhibit Hall
Enjoy facilitated networking opportunities with over 100 qualified delegates by participating as an exhibitor. Spread awareness of your latest products or services, as well as your unique corporate image.
Sponsorship Information:
Showcase your company's expertise, brand your solutions and develop revenue opportunities with qualified decision-makers by becoming an active Corporate Sponsor. We can customize any opportunity to meet your current marketing and sales objectives.
####
For more information, please click here
Contacts:
Sean Song
Program Coordinator
Organizing Committee of IDDST-2009
26 Gaoneng St., R401
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799479
Fax: 0086-411-84799629
Copyright © IDDST-2009
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||